Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
110
110 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- PF-0704091Phase 21 trial
Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
- REGN5668ubletamigPhase 21 trial
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- TER-2013Phase 21 trial
Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer
- TILT-123Ad5, 3-E2F-d24-hTNFa-IRES-hIL2Phase 21 trial
TILT Biotherapeutics Ltd. · Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma
- TJ102Phase 21 trial
Phrontline Biopharma · Ovarian Cancer
- VB15010Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast
- VLS-1488Phase 21 trial
Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.